iShares Neuroscience and Healthcare ETF
IBRN
5 hedge funds and large institutions have $2.23M invested in iShares Neuroscience and Healthcare ETF in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
13.04% less ownership
Funds ownership: 58.17% → 45.13% (-13%)
21% less capital invested
Capital invested by funds: $2.82M → $2.23M (-$589K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPIA
Steward Partners Investment Advisory
New York
|
+$687K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$96 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.31M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$801 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $1.52M | -$1.31M | -41,000 | -47% |
|
|
SPIA
2
Steward Partners Investment Advisory
New York
| $707K | +$687K | +21,459 | New |
|
3
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $5.37K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $2.21K | -$801 | -25 | -27% |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| $98 | +$96 | +3 | New |
|
IBRN Hedge Fund Activity: Q1 2026 in Review
5 of the 8,141 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q1 2026, worth a combined $2.23M — down 21% from $2.82M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IBRN positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Steward Partners Investment Advisory, opening a new position worth an estimated $687K. The largest seller was BlackRock, cutting an estimated $1.31M.
- 5 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q1 2026, up from 3 in Q4 2025.
- Funds reported $2.23M of iShares Neuroscience and Healthcare ETF stock for Q1 2026, down 21% quarter-over-quarter.
- 2 funds opened new iShares Neuroscience and Healthcare ETF positions in Q1 2026 and 0 closed out, a net change of +2 holders.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q1 2026 was Steward Partners Investment Advisory, an estimated $687K added.
- The largest iShares Neuroscience and Healthcare ETF seller in Q1 2026 was BlackRock, an estimated $1.31M sold.
Based on aggregated 13F filings for Q1 2026.